Steve M.

Steve M. has a long and varied work experience. In 2021, they became the Chief Executive Officer of Macomics, a company developing novel immunotherapies for cancer treatment. Steve also joined Prostate Cancer Research as a member of the Translational Scientific Advisory Committee and the Enterprise Mentorship scheme at the University of Cambridge. In 2017, they became the Chief Executive Officer of Azeria Therapeutics Limited and a Non Executive Director of NeoPhore Ltd. From 2015 to 2012, they were a Partner and Associate at SIXTH ELEMENT CAPITAL LLP. From 2014 to 2010, they were the Head of Alliances and Business Development Manager and Project Development Manager at Cancer Research Technology.

Steve M. attended The University of Sheffield from 1999 to 2002, where they earned a BSc (Hons) in Pharmacology.